Edition:
United States

Insider Trading: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

61.13USD
2 Dec 2016
Change (% chg)

$0.37 (+0.61%)
Prev Close
$60.76
Open
$61.10
Day's High
$61.51
Day's Low
$60.63
Volume
2,659,161
Avg. Vol
3,164,739
52-wk High
$65.45
52-wk Low
$47.97

All Insider Trades
Trading Date Name Title Type Shares Traded Price
3 Aug 2016

Ambrose Adele D

Officer Sell 7,000 $57.80
1 Aug 2016

Chattopadhyay (Sanat)

Officer Buy 5,150 $0.00
1 Aug 2016

Chattopadhyay (Sanat)

Officer Sell 1,619 $58.66
1 Aug 2016

Frazier (Kenneth C)

Chief Executive Officer Gift 13,600 $0.00
4 Jul 2016

Graddick-Weir (Mirian M)

Officer Sell 36,000 $58.00
4 Jul 2016

Graddick-Weir (Mirian M)

Officer Sell 9,000 $57.92
4 Jul 2016

Frazier (Kenneth C)

Chief Executive Officer Buy 27,621 $51.02
4 Jul 2016

Frazier (Kenneth C)

Chief Executive Officer Sell 27,621 $58.00
30 Jun 2016

Graddick-Weir (Mirian M)

Officer Sell 30,000 $57.49
30 Jun 2016

Frazier (Kenneth C)

Chief Executive Officer Buy 32,379 $51.02
30 Jun 2016

Schechter (Adam H)

Officer Sell 50,000 $57.69
30 Jun 2016

Graddick-Weir (Mirian M)

Officer Buy 30,000 $40.70
30 Jun 2016

Frazier (Kenneth C)

Chief Executive Officer Sell 32,379 $58.00
30 Jun 2016

Schechter (Adam H)

Officer Buy 50,000 $44.30
19 May 2016

Golestani (Clark)

Chief Technology Officer Sell 38,647 $54.80
19 May 2016

Golestani (Clark)

Chief Technology Officer Buy 38,647 $44.98
18 May 2016

Golestani (Clark)

Chief Technology Officer Sell 1,230 $54.55
9 May 2016

Holston Michael J

General Counsel Sell 100,021 $54.50
9 May 2016

Holston Michael J

General Counsel Buy 42,942 $44.98
9 May 2016

Holston Michael J

General Counsel Buy 57,079 $44.28
5 May 2016

Gerberding (Julie L)

Officer Sell 1,566 $54.09
5 May 2016

Gerberding (Julie L)

Officer Buy 4,002 $0.00
5 May 2016

Ambrose Adele D

Officer Buy 3,335 $0.00
5 May 2016

Perlmutter (Roger M)

Officer Sell 26,946 $54.09
5 May 2016

Karachun (Rita A)

Officer Buy 2,001 $0.00

Institutional Holders

% Shares Owned: 74.51%
# of Holders: 2,324
Total Shares Held: 2,054,425,740
3 Mo. Net Change: -7,179,377
# New Positions: 123
# Closed Positions: 49
# Increased Positions: 892
# Reduced Positions: 888
# Net Buyers: 4

Officers & Directors

Name Age Since Current Position

Kenneth Frazier

61 2011 Chairman of the Board, President, Chief Executive Officer

Robert Davis

49 2014 Chief Financial Officer, Executive Vice President

Clark Golestani

49 2012 Executive Vice President, Chief Information Officer

Michael Holston

53 2015 Executive Vice President, General Counsel

Mirian Graddick-Weir

61 2009 Executive Vice President - Human Resources

Sanat Chattopadhyay

2016 Executive Vice President and President - Merck Manufacturing Division

Richard DeLuca

53 2011 Executive Vice President, President - Merck Animal Health

Julie Gerberding

60 2015 Executive Vice President - Strategic Communications, Global Public Policy & Population Health

Roger Perlmutter

64 2013 Executive Vice President, President - Merck Research Laboratories

Michael Rosenblatt

68 2009 Executive Vice President, Chief Medical Officer

Adam Schechter

51 2010 Executive Vice President, President - Global Human Health

Rita Karachun

52 2014 Senior Vice President Finance - Global Controller

Adele Ambrose

59 2009 Senior Vice President, Chief Communications Officer

Leslie Brun

63 2016 Lead Independent Director

Thomas Cech

69 2009 Independent Director

Pamela Craig

59 2015 Independent Director

Thomas Glocer

56 2007 Independent Director

C. Robert Kidder

71 2005 Independent Director

Rochelle Lazarus

68 2004 Independent Director

Carlos Represas

71 2009 Independent Director

Paul Rothman

58 2015 Independent Director

Patricia Russo

64 1995 Independent Director

Craig Thompson

63 2008 Independent Director

Wendell Weeks

56 2004 Independent Director

Peter Wendell

65 2003 Independent Director

Joseph Romanelli

2015 IR Contact Officer